- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Asia Pacific Dermatology Diagnostic Devices Market Size
The size of the Asia Pacific dermatology diagnostic devices market was valued at USD 5.69 billion in 2024 and is anticipated to reach USD 11.19 billion by 2033, growing at a CAGR of 7.80% from 2024 to 2033.
MARKET OVERVIEW
Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding aesthetics. This has led to rising awareness about various types of aesthetic procedures used for treating hair- and skin-related disorders. Primarily, women suffer from these disorders. Therefore, they are the highest revenue makers in the market.
Increasing the incidence of skin disorders, growing awareness regarding aesthetic procedures, technological advancements, and rising healthcare expenditure are the primary drivers of the market.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| Segments Covered | By Type, Application, Dermatoscopes, and Country. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC |
| Market Leaders Profiled | 3Gen Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Valeant Pharmaceuticals (Canada), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.). |
COUNTRY LEVEL ANALYSIS
The imaging devices category is anticipated to command the largest share of the market during the aforementioned forecast period. It is due to the technological advancements and rising awareness regarding aesthetic procedures. The skin cancer diagnosis segment is expected to account for the largest share of the market during the forecast period.
It is the third-largest market. Asia is anticipated to experience the highest CAGR during the aforementioned forecast period, with the development in this market centered on Japan, China, and India. Increasing the incidence of skin diseases, rising healthcare expenditure, and growing awareness regarding aesthetic procedures are the reasons attributable to the observable trend mentioned above.
KEY MARKET PLAYERS
The Top companies leading in the Asia Pacific Dermatology Diagnostic Devices Market profiled in the report are 3Gen Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Valeant Pharmaceuticals (Canada), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.).
MARKET SEGMENTATION
This research report on the Asia Pacific Dermatology Diagnostic Devices Market has been segmented and sub-segmented into the following categories.
By Type
- Dermatoscopes
- Microscopes
- Imaging Devices
By Application
- Skin Cancer Diagnosis
- Other Diagnostic Applications
By Dermatoscopes
- Contact Oil Immersion Dermatoscopes
- Cross-Polarized Dermatoscopes
- Hybrid Dermatoscopes
By Country
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of Asia Pacific